CORONA, Calif.—Branded and generic drug maker Watson Pharmaceuticals Inc. reaffirmed its full-year profit outlook Thursday, the midpoint of which meets Wall Street forecasts.
The company expects adjusted profit between $1.90 and $2.00 per share. Analysts polled by Thomson Financial expect a profit of $1.95 per share.
Charges during the year will include about $32 million related to plant closure costs and $6 million in licensing costs.
© Copyright 2008 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
rising
falling 